Press Release: Carolina Molecular Brings AVITI™ Sequencing to the Southeast

Read More

Now accepting sample submissions for the Element AVITI™ platform

Request Quote
Contact Us

Trustworthy Clinical Testing

More sequencing capacity than ever. Fewer clinical labs to handle it. We’re here to help.

Schedule a Consultation

Clinical Lab Expertise When You Need it Most

Despite the large amount of next generation sequencing capacity today, there is a shortage of accredited molecular laboratories capable of meeting the needs of today’s clinical programs. Carolina Molecular provides the reliable, scalable clinical testing services you need.

Get Started, Hassle Free

  • Scheduling is transparent and efficient with our highly responsive project management teams.
  • Pricing is flexible across scale with low minimums.
Get a Quote Today

Enabling Partners Through Molecular Testing

Carolina Molecular works with CRO and technology partners to extend the breadth and depth of their offerings with molecular testing services in 3 focus areas:

Oncology

  • Solid Tumor
  • Blood Cancer
  • MRD & liquid biopsy
  • Methylation

Infectious Disease

  • De novo ID
  • Metagenomics
  • QPRC
  • Genotyping

Immunology

  • HLA
  • Immune Profiling
  • Spatial expression
  • Proteomic profiling
  • Single-cell

Carolina’s clinical genomics workflow: from planning to reporting

Cohort definition and analysis, depth considerations and run optimization
Experienced with comprehensive range of sample requirements
Allele- or target-specific quantitative detection
Maximum confidence and flexibility with multiple Illumina short read systems, and high throughput Sanger sequencing
RNAseq, nCounter or GeoMX platforms, Plasma Proteomics, Luminex
Visit Bioinformatics Page

Reliable Clinical Testing Services

  • RNA Seq (degraded FFPE and blood)
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • FFPE processing/extraction capabilities
Visit Foundry NGS Page
  • Liquid Biopsy
  • Single Cell Sequencing
  • Solid Tumor Profiling
  • Myeloid MRD Panels (RNA and DNA)
  • Primary, secondary and tertiary analysis
  • Consultative discussion and experimental planning
  • Custom pipeline and report development
  • Able to validate client-developed assays across testing modalities
  • Supporting a wide range of therapeutic areas

*CAP/CLIA (NYS) since 2017, 50 validated molecular assays, over 200 clients serviced.

Comprehensive Molecular Analysis Capabilities

Extraction, Handling, and Analysis of Multiple Sample Types

Clinical

  • Whole Blood
  • Buccal Swab
  • Saliva
  • Fecal
  • Aspirates, Urine Swabs, and Cerebral Spinal Fluid

Research

  • Human
  • Animal
  • Plant
  • Bacteria/Fungi
  • Envrionmental
  • Viruses/Phages
  • Viruses/Phages
  • Pre-pool Libraries

Solid Tumor

  • Onco/Reveal Solid Tumor
  • VariantPlex Solid Tumor
  • FusionPlex Solid Tumor
  • OncoMine
  • EGFR
  • TP53

Blood Cancers

  • Onco/Reveal Myeloid
  • FusionPlex Myeloid
  • CLL Panel
  • IGHV
  • FLT3

How to Work with Us

Intro

Pricing Estimate
Technical Call
Quote
Assay Design
Test Execution
Reporting
Consultation Request

Request a Quote

Request a Quote